The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $236.35

Today's change0.00 0.00%
Updated April 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $236.35

Today's change0.00 0.00%
Updated April 21 4:00 PM EDT. Delayed by at least 15 minutes.

Allergan plc closed at (U.S.)$236.35.

Shares have lost 0.62% over the last five days, but have gained 12.54% over the last year to date. This security has underperformed the S&P 500 by 8.40% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $236.35
  • High--
  • Low--
  • Bid / Ask(U.S.) $237.28 / (U.S.) $238.70
  • YTD % change+12.54%
  • Volume183
  • Average volume (10-day)1,783,769
  • Average volume (1-month)2,506,422
  • Average volume (3-month)3,377,125
  • 52-week range(U.S.) $184.50 to (U.S.) $261.27
  • Beta1.16
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward14.75×
  • Forward PEG1.06×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.18%
  • Trailing EPS(U.S.) -$3.12
Updated April 21 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue3,8643,6223,6853,399
Total other revenue--------
Total revenue3,8643,6223,6853,399
Gross profit3,3853,1603,2432,922
Total cost of revenue480462442477
Total operating expense4,7643,8894,1723,571
Selling / general / administrative1,2771,1571,2101,096
Research & development1,340665905409
Depreciation / amortization1,6391,6091,6331,590
Interest expense (income), net operating--------
Unusual expense (income)29-5-18-2
Other operating expenses, total--------
Operating income-900-266-488-172
Interest income (expense), net non-operating-293-324-346-333
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,111-539-681-501
Income after tax-40-380-423-92
Income tax, total-1,071-159-258-409
Net income-115,220-502256
Total adjustments to net income-70-70-70-70
Net income before extra. items-42-382-424-93
Minority interest-2-2-2-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-112-452-494-163
Inc. avail. to common incl. extra. items-7015,150-571186
Diluted net income-7015,150-571186
Dilution adjustment--------
Diluted weighted average shares356393396395
Diluted EPS excluding extraordinary itemsvalue per share-0.31-1.15-1.25-0.41
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.26-1.16-1.28-0.41